Search research articles
Contact Us
Filters
Showing results (21-30 of 98) with videos related to
Page
of 10
Sort By:
Frontiers in Oncology
|
April 16, 2025
Emapalumab for severe cytokine release syndrome in solid tumor CAR-T: a case report
Tyler Ruemmele, Rodney Macedo, Mark N Stein, et al.
Frontiers in Oncology
|
June 17, 2017
Surgical Management of Advanced and Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach
Brian M Shinder, Kevin Rhee, Douglas Farrell, et al.
The Oncologist
|
April 4, 2022
ADXS31142 Immunotherapy ± Pembrolizumab Treatment for Metastatic Castration-Resistant Prostate Cancer: Open-Label Phase I/II KEYNOTE-046 Study
Mark N Stein, Lawrence Fong, Ronald Tutrone, et al.
The American Journal of Medicine
|
March 15, 2011
Patterns and correlates of prostate cancer treatment in older men
Calpurnyia B Roberts, Peter C Albertsen, Yu-Hsuan Shao, et al.
Journal of the National Cancer Institute
|
August 29, 2009
Contemporary risk profile of prostate cancer in the United States
Yu-Hsuan Shao, Kitaw Demissie, Weichung Shih, et al.
Archives of Internal Medicine
|
July 28, 2010
Risk profiles and treatment patterns among men diagnosed as having prostate cancer and a prostate-specific antigen level below 4.0 ng/ml
Yu-Hsuan Shao, Peter C Albertsen, Calpurnyia B Roberts, et al.
Investigational New Drugs
|
August 11, 2010
Phase I study of gemcitabine, docetaxel and imatinib in refractory and relapsed solid tumors
Biren Saraiya, Rashmi Chugh, Vassiliki Karantza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 2014
Adjuvant and salvage radiotherapy after prostatectomy: American Society of Clinical Oncology clinical practice guideline endorsement
Stephen J Freedland, R Bryan Rumble, Antonio Finelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2007
Phase I and pharmacokinetic study of imatinib mesylate (Gleevec) and gemcitabine in patients with refractory solid tumors
Yaqoob Ali, Yong Lin, Mecide M Gharibo, et al.
Clinical Genitourinary Cancer
|
October 19, 2015
A Phase II Study of AT-101 to Overcome Bcl-2--Mediated Resistance to Androgen Deprivation Therapy in Patients With Newly Diagnosed Castration-Sensitive Metastatic Prostate Cancer
Mark N Stein, Maha Hussain, Walter M Stadler, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 98) with videos related to
Sort By:
Page
of 10
Frontiers in Oncology
|
April 16, 2025
Emapalumab for severe cytokine release syndrome in solid tumor CAR-T: a case report
Tyler Ruemmele, Rodney Macedo, Mark N Stein, et al.
Frontiers in Oncology
|
June 17, 2017
Surgical Management of Advanced and Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach
Brian M Shinder, Kevin Rhee, Douglas Farrell, et al.
The Oncologist
|
April 4, 2022
ADXS31142 Immunotherapy ± Pembrolizumab Treatment for Metastatic Castration-Resistant Prostate Cancer: Open-Label Phase I/II KEYNOTE-046 Study
Mark N Stein, Lawrence Fong, Ronald Tutrone, et al.
The American Journal of Medicine
|
March 15, 2011
Patterns and correlates of prostate cancer treatment in older men
Calpurnyia B Roberts, Peter C Albertsen, Yu-Hsuan Shao, et al.
Journal of the National Cancer Institute
|
August 29, 2009
Contemporary risk profile of prostate cancer in the United States
Yu-Hsuan Shao, Kitaw Demissie, Weichung Shih, et al.
Archives of Internal Medicine
|
July 28, 2010
Risk profiles and treatment patterns among men diagnosed as having prostate cancer and a prostate-specific antigen level below 4.0 ng/ml
Yu-Hsuan Shao, Peter C Albertsen, Calpurnyia B Roberts, et al.
Investigational New Drugs
|
August 11, 2010
Phase I study of gemcitabine, docetaxel and imatinib in refractory and relapsed solid tumors
Biren Saraiya, Rashmi Chugh, Vassiliki Karantza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 2014
Adjuvant and salvage radiotherapy after prostatectomy: American Society of Clinical Oncology clinical practice guideline endorsement
Stephen J Freedland, R Bryan Rumble, Antonio Finelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2007
Phase I and pharmacokinetic study of imatinib mesylate (Gleevec) and gemcitabine in patients with refractory solid tumors
Yaqoob Ali, Yong Lin, Mecide M Gharibo, et al.
Clinical Genitourinary Cancer
|
October 19, 2015
A Phase II Study of AT-101 to Overcome Bcl-2--Mediated Resistance to Androgen Deprivation Therapy in Patients With Newly Diagnosed Castration-Sensitive Metastatic Prostate Cancer
Mark N Stein, Maha Hussain, Walter M Stadler, et al.
Page
of 10